People: Sino Biopharmaceutical Ltd (1177.HK)
20 May 2019
Mr. Tse Ping serves as Chief Executive Officer, Executive Director of the Company. He is responsible for the overall operations of the Group. With more than 25 years of extensive experience in investment and management in the pharmaceutical industry in China, he is currently a director of CT Tianqing, NJCTT, Jiangsu CT Fenghai, Jiangsu CT Qingjiang, Qingdao CT, and Beijing Tide. He is also a director of Shanghai Fortune World Development Co., Ltd., Tianjin Chiatai Feed Tech Co., Ltd., SYN Energy Technology Co., Ltd. and Chia Tai Oversea Chinese Realty Development Co., Ltd., and a non- executive director of Tianjin Binhai Teda Logistics (Group) Corporation Limited, the shares of which are listed on GEM Board of the Stock Exchange. Mr. Tse still acts as a director of Chia Tai Qingchunbao Pharmaceutical Co., Ltd. and a council member of the Association of Pharmaceutical Biotechnology of China.
|Total Annual Compensation, HKD||36,727,000|
|Restricted Stock Award, HKD||--|
|Long-Term Incentive Plans, HKD||--|
|All Other, HKD||--|
|Fiscal Year Total, HKD||36,727,000|